Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Gentamicin-induced stop codon readthrough shows benefit in a retinitis pigmentosa rat model

May 9, 2007

Topically applied TG-101095 shows promise in a murine laser-induced CNV model

May 9, 2007

The mTOR inhibitor QLT-0447 potently suppresses CNV in vivo

May 9, 2007

Ista withdraws European application for Vitragan

May 9, 2007

Sphingozumab effective in animal models of laser-induced CNV

May 9, 2007

Immunotherapy with MHC II-expressing tumor cells may be useful in uveal melanoma

May 8, 2007

AL-39324 reduces ocular angiogenesis in different animal models in vivo

May 8, 2007

Ista receives non approvable letter for T-Pred

May 7, 2007

Lux receives Canadian clearance for phase II/III trials of LX-211 in uveitis

May 7, 2007

In vivo antiangiogenic activity of Immusol's new compound, IMS-2186

May 7, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...